Cargando…
Targeting the insulin-like growth factor-1 receptor in human cancer
The insulin-like growth factor (IGF) signaling system plays a crucial role in human cancer and the IGF-1 receptor (IGF-1R) is an attractive drug target against which a variety of novel anti-tumor agents are being developed. Deregulation of the IGF signaling pathway frequently occurs in human cancer...
Autor principal: | Arcaro, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605519/ https://www.ncbi.nlm.nih.gov/pubmed/23525758 http://dx.doi.org/10.3389/fphar.2013.00030 |
Ejemplares similares
-
Application of insulin-like growth factor-1 in the treatment of inner ear disorders
por: Yamamoto, Norio, et al.
Publicado: (2014) -
Insulin-Like Growth Factor Binding Proteins in Kidney Disease
por: Wang, Shuqiang, et al.
Publicado: (2021) -
Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
por: Pejchal, Jaroslav, et al.
Publicado: (2022) -
Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2014) -
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
por: Yang, ZiYan, et al.
Publicado: (2021)